Modulation of Mu-Opioid Receptor Signaling by Cannabinoid CB1 Receptor Through Heteromerization, a Novel Analgesic Target

Biophysical Journal - United States
doi 10.1016/j.bpj.2018.11.1287
Full Text
Abstract

Available in full text

Categories
Biophysics
Date
Authors
Publisher

Elsevier BV

Related search

Μ Opioid and CB1 Cannabinoid Receptor Interactions: Reciprocal Inhibition of Receptor Signaling and Neuritogenesis

British Journal of Pharmacology
Pharmacology
2009English

Heteromerization Modulates Mu Opioid Receptor Functional Properties in Vivo

Frontiers in Pharmacology
Pharmacology
2018English

A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding

Journal of Neuroscience
Neuroscience
2002English

Receptor Heteromerization Expands the Repertoire of Cannabinoid Signaling in Rodent Neurons

PLoS ONE
Multidisciplinary
2012English

Modulation of Feeding and Locomotion Through Mu and Delta Opioid Receptor Signaling in the Nucleus Accumbens

Neuropeptides
Molecular NeuroscienceEndocrineEndocrinologyAutonomic SystemsNeurologyCellularMedicine
2010English

Functional Characterization of the Novel Cannabinoid Receptor GPR55 and Its Modulation by CB1 and CB2 Receptors

BMC Pharmacology
2008English

Μ-Opioid Receptor Forms a Functional Heterodimer With Cannabinoid CB1 Receptor: Electrophysiological and FRET Assay Analysis

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2008English

Mechanisms of CB1 Receptor Signaling: Endocannabinoid Modulation of Synaptic Strength

International Journal of Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2006English

Synergistic Attenuation of Chronic Pain Using Mu Opioid and Cannabinoid Receptor 2 Agonists

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy